International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.09 and traded as high as $0.10. International Stem Cell shares last traded at $0.10, with a volume of 800 shares trading hands.
International Stem Cell Price Performance
The stock has a market capitalization of $808,404.00, a price-to-earnings ratio of -1.26 and a beta of 0.05. The firm’s fifty day moving average is $0.11 and its 200-day moving average is $0.09.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Stories
- Five stocks we like better than International Stem Cell
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Can TikTok Stock Picks Really Make You Rich?
- Dividend Payout Ratio Calculator
- The “Quality” Rotation: Back to Basics Investing
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
